On the cardiovascular and beta-adrenergic blocking effects produced in the beagle dog by repeated oral administration of talinolol (Cordanum) and propranolol
Heer, S.; Femmer, K.
Die Pharmazie 34(5-6): 317-320
1980
ISSN/ISBN: 0031-7144 PMID: 6106208 Document Number: 165550
Document emailed within 1 workday
Related Documents
Terhaag, B.; Richter, K.; Pötter, H. 1983: Pharmacokinetics of talinolol (Cordanum) in man after oral administration Die Pharmazie 38(8): 568-569Bellomo, G.; Santucci, S.; Murrone, A.; Santambrogio, L.; Gennari, M.; Stangoni, G. 1988: Effects of calcium antagonists and beta-adrenergic receptor blocking agents on cardiovascular rhythmicity Panminerva Medica 30(4): 236-239
Frick, M.H.; Hartikainen, M.; Pörsti, P. 1978: Penbutolol, a new non-selective beta-adrenergic blocking compound in the treatment of hypertension. A comparision with propranolol Annals of Clinical Research 10(2): 105-106
Gastmeier, G.; Eulitz, J. 1978: Fatal talinolol (Cordanum) intoxication Die Pharmazie 33(7): 463-464
Sternitzke, N.; Schieffer, H.; Hoffmann, W.; Bette, L. 1976: Modification of the cardiovascular-dynamic effect of Akrinor following the blockade of adrenergic beta receptors with propranolol Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1132-1135
Sziegoleit, W.; Block, H.U.; Fahr, A.; Mest, H.J. 1991: Serum thromboxane B2 after intravenous administration of talinolol and propranolol in healthy subjects Die Pharmazie 46(1): 58-59
Privitera, P.J.; Blickenstaff, T.; Gaffney, T.E.; Mohammed, S. 1971: Adrenergic blocking and cardiovascular effects of a new N-substituted tetrahydroisoquinoline (NC 7197) Journal of Pharmacology and Experimental Therapeutics 176(3): 655-661
Harms, H.H. 1976: Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors Journal of Pharmacology and Experimental Therapeutics 199(2): 329-335
Greenberg, L.H.; Weiss, B. 1979: Ability of aged rats to alter beta adrenergic receptors of brain in response to repeated administration of reserpine and desmethylimipramine Journal of Pharmacology and Experimental Therapeutics 211(2): 309-316
Nosál', R.; Drábiková, K.; Pecivová, J. 1988: Adverse effects of beta-adrenergic receptor blocking agents on the cellular level Casopis Lekaru Ceskych 127(5): 133-136
Apponi-Battini, G.; Barra, A.; De Simone, C.; Rossi, F.; Berrino, L.; Cazzola, M.; Marmo, E. 1984: Systemic and ocular effects of alpha 2-adrenergic stimulating and beta 2-blocking agents Journal of Medicine 15(2): 126-134
Lydtin, H.; Lohmöller, G.; Daniel, W.; Schierl, W.; Schewe, S.; Kempter, H.; Lohmöller, R.; Walter, I.; Kusus, T. 1971: Cardiovascular effects of glucagon before and following propranolol administration Verhandlungen der Deutschen Gesellschaft für Innere Medizin 77: 1000-1004
Leshchinskiĭ, L.A.; Logacheva, I.V.; Nikolaeva, V.A.; Plastinina, R.A.; Polischuk, M.A. 1983: Effect of the combined administration of alpha- and beta-adrenergic blockaders (propranolol and phentolamine) on central and renal hemodynamics during the treatment of patients with arterial hypertension Terapevticheskii Arkhiv 55(9): 48-51
Ban, T. 1974: A quantitative study of the effects of isoproterenol and beta-adrenergic blocking agents in the rat uterus in situ Arzneimittel-Forschung 24(2): 179-181
Dufour, R.; Scazziga, B.; Schelling, J.L. 1970: Acute circulatory effects of a beta adrenergic blocking agent (LB 46) in patients with sympathetic overstimulation Internationale Zeitschrift für Klinische Pharmakologie Therapie und Toxikologie. International Journal of Clinical Pharmacology Therapy and Toxicology 4(1): 145-147
Ongini, E.; Milani, S.; Marzanatti, M.; Trampus, M.; Monopoli, A. 1991: Effects of selected beta-adrenergic blocking agents on sleep stages in spontaneously hypertensive rats Journal of Pharmacology and Experimental Therapeutics 257(1): 114-119
Shmidt, I.; Khomut, V.; Monike, V.; Bakh, K.; Fliugel', K. 1985: Central and peripheral hemodynamics during combined treatment of arterial hypertension with calcium antagonist nifedipine and beta-adrenergic blockader talinolol Kardiologiia 25(6): 110-111
Duggan, M.A.; Court, J.B. 1981: A proposed mechanism of production of the autoimmune and lymphoproliferative side-effects of beta-adrenergic-site-blocking drugs and hydantoin anticonvulsants Annals of Clinical Research 13(6): 406-418
Yoshida, T.; Takano, M.; Tamura, A.; Kubota, H.; Suzuki, N. 1970: Cardiovascular effects and antiarrhythmic action of a new beta adrenergic blocker, LB-46 Masui. Japanese Journal of Anesthesiology 19(5): 515-522
Funahashi, N.; Shimizu, N.; Mori, H.; Akie, Y.; Kobayashi, Y.; Kobayashi, Y.; Watanabe, Y.; Ishizuka, S.; Nagasawa, K.; Kotobuki, A. 1990: Four-week repeated dose oral toxicity study of BMY-28100 in juvenile beagle dogs Japanese Journal of Antibiotics 43(7): 1260-1274